Chrissy Metz Discloses GLP-1 Use Amid Shift in Weight Management Approach "This Is Us" actress Chrissy Metz has begun using GLP-1 medication to assist with her health journey, citing long-term struggles with weight and persistent "food noise." Metz, 45, is partnering with the telehealth company Ro to manage her treatment, marking a departure from her … Read more
Hilaria Baldwin revealed during a July 28 interview on SiriusXM’s Page Six Radio that she started dieting at just 5 years old, a personal disclosure that highlights how early disordered eating patterns can begin. According to the mom of seven, now 42, her decades-long struggle spanned multiple extremes, including anorexia, bulimia, overeating, and undereating. Baldwin … Read more
According to a clinical study published in Obesity Pillars, participants taking the dietary supplement Calocurb lost an average of 8.3 pounds over 24 weeks while maintaining lean muscle mass. The findings arrive as consumers and researchers increasingly scrutinize popular GLP-1 weight loss treatments for causing significant reductions in lean muscle alongside fat loss. Understanding Calocurb … Read more
How Menopause Impacts Body Image and Self-Esteem Country singer Shania Twain has openly discussed her struggles with body image during menopause, revealing she experienced bloating and a loss of control over her body. “In menopause you lose control of your body,” she told The Sunday Times. “I stopped looking at myself in the mirror. I … Read more
A Hawke’s Bay mother has launched a formal complaint with the Health and Disability Commissioner (HDC) after her infant daughter was hospitalized twice for “failure to thrive,” a condition she alleges went unmonitored by her Tamariki Ora provider. The infant, Soleia, lost 400 grams in three days and dropped to the second percentile in growth, … Read more
The rising adoption of GLP-1 receptor agonists (RAs) is triggering a major pivot in the food and supplement sectors, as manufacturers race to develop companion products for weight-loss patients. Approximately 12% of U.S. adults have utilized these therapies, according to industry data. Experts from companies like Gnosis by Lesaffre, Kerry, and ADM report that this … Read more
Beyond the Low-Carb Craze: The New Science of Metabolic Balance For decades, the nutritional world has been locked in a tug-of-war over carbohydrates. One year they are the enemy; the next, they are the essential fuel for the brain. But as emerging research from experts like Professor Matsumura suggests, the conversation is shifting. It’s no … Read more
Beyond Weight Loss: How New Drugs Could Revolutionize Heart Health The rise of medications like semaglutide (Ozempic, Wegovy) has been largely focused on their dramatic effects on weight loss. Still, emerging research reveals a potentially far more significant benefit: protection against cardiovascular disease. These GLP-1 receptor agonists are now being recognized not just as diabetes … Read more
The Rising Tide of Weight Loss Drugs and Eating Disorder Risk: A Looming Public Health Concern The increasing visibility of GLP-1 receptor agonists (GLP-1 RAs) – medications initially designed for type 2 diabetes, now widely used for weight loss – is creating a complex and potentially dangerous landscape for individuals vulnerable to eating disorders. Experts … Read more
Beyond the Shot: The Future of Weight Loss and Maintaining Results Ozempic, Wegovy, and similar GLP-1 medications have revolutionized weight loss, but lasting success hinges on a shift towards holistic health strategies. Updated: February 2, 2026 The dramatic weight loss achieved by patients using medications like Ozempic and Wegovy has captured public attention, offering hope … Read more